Suppr超能文献

患有终末期肾病的肝移植受者在很大程度上受益于肾移植。

Liver Transplant Recipients With End-Stage Renal Disease Largely Benefit From Kidney Transplantation.

作者信息

Yunhua T, Qiang Z, Lipeng J, Shanzhou H, Zebin Z, Fei J, Zhiheng Z, Linhe W, Weiqiang J, Dongping W, Zhiyong G, Xiaoshun H

机构信息

Organ Transplant Center, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China; Guangdong Provincial Key Laboratory of Organ Donation and Transplant Immunology, Guangzhou, China; Guangdong Provincial International Cooperation Base of Science and Technology, Guangzhou, China.

Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-Sen University, Guangzhou, China.

出版信息

Transplant Proc. 2018 Jan-Feb;50(1):202-210. doi: 10.1016/j.transproceed.2017.11.009.

Abstract

BACKGROUND

The incidence of end-stage renal disease (ESRD) after liver transplant (LT) has increased. The actual benefit of kidney transplantation (KT) is not completely understood in LT recipients with ESRD.

METHODS

We analyzed Scientific Registry of Transplant Recipients data for all KT candidates with prior LT from 1998 to 2014; the benefits of KT relative to remaining on dialysis were compared by means of multivariate Cox proportional hazards regression analysis.

RESULTS

The number of these KT candidates with prior LT has tripled from 98 in 1998 to 323 in 2015; LT recipients with ESRD remaining on dialysis have a 2.5-times increase in the risk of liver graft failure and a 3.6-times increase in the risk of patient death compared with these patients receiving KT. The adjusted liver graft and patient survival rates after donors from donation after cardiac death or expanded-criteria donor kidney transplantation were significantly higher than in patients remaining on dialysis in LT recipients with ESRD.

CONCLUSIONS

The number of referrals to KT with prior LT is increasing at a rapid rate. Remaining on dialysis in LT recipients with ESRD has profound increased risks of liver graft failure and patient death in comparison to receiving a KT. LT recipients with ESRD can benefit from expanded-criteria donor and donation after cardiac death kidney transplantation.

摘要

背景

肝移植(LT)后终末期肾病(ESRD)的发病率有所上升。对于患有ESRD的LT受者,肾移植(KT)的实际益处尚未完全明确。

方法

我们分析了1998年至2014年所有曾接受LT的KT候选者在移植受者科学注册系统中的数据;通过多变量Cox比例风险回归分析比较了KT相对于继续接受透析的益处。

结果

这些曾接受LT的KT候选者数量已从1998年的98例增至2015年的323例,增长了两倍;与接受KT的患者相比,患有ESRD且继续接受透析的LT受者肝移植失败风险增加2.5倍,患者死亡风险增加3.6倍。在患有ESRD的LT受者中,接受心脏死亡后捐赠或扩大标准供体肾移植的供体进行移植后,调整后的肝移植和患者生存率显著高于继续接受透析的患者。

结论

曾接受LT后转诊至KT的人数正在迅速增加。与接受KT相比,患有ESRD的LT受者继续接受透析会显著增加肝移植失败和患者死亡的风险。患有ESRD的LT受者可从扩大标准供体和心脏死亡后捐赠肾移植中获益。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验